Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $7.29 in the prior trading day, Zenas Biopharma Inc (NASDAQ: ZBIO) closed at $7.62, up 4.53%. In other words, the price has increased by $4.53 from its previous closing price. On the day, 0.54 million shares were traded. ZBIO stock price reached its highest trading level at $7.9568 during the session, while it also had its lowest trading level at $6.89.
Ratios:
Our goal is to gain a better understanding of ZBIO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.95 and its Current Ratio is at 8.95. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 16, 2024, initiated with a Buy rating and assigned the stock a target price of $30.
On November 05, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $34.
On October 08, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $40.Morgan Stanley initiated its Overweight rating on October 08, 2024, with a $40 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 04 ’24 when MOULDER LEON O JR bought 45,000 shares for $9.98 per share. The transaction valued at 449,100 led to the insider holds 241,155 shares of the business.
MOULDER LEON O JR bought 25,000 shares of ZBIO for $269,000 on Dec 03 ’24. The Chief Executive Officer now owns 196,155 shares after completing the transaction at $10.76 per share. On Nov 18 ’24, another insider, MOULDER LEON O JR, who serves as the Chief Executive Officer of the company, bought 7,500 shares for $15.00 each. As a result, the insider paid 112,500 and bolstered with 168,655 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZBIO now has a Market Capitalization of 318447424.
Stock Price History:
Over the past 52 weeks, ZBIO has reached a high of $26.25, while it has fallen to a 52-week low of $5.83. The 50-Day Moving Average of the stock is -21.94%, while the 200-Day Moving Average is calculated to be -47.20%.
Shares Statistics:
The stock has traded on average 314.76K shares per day over the past 3-months and 192930 shares per day over the last 10 days, according to various share statistics. A total of 41.78M shares are outstanding, with a floating share count of 11.32M. Insiders hold about 76.39% of the company’s shares, while institutions hold 25.65% stake in the company. Shares short for ZBIO as of 1736899200 were 3216251 with a Short Ratio of 10.60, compared to 1734048000 on 2130663.
